Trials / Conditions / Pyoderma
Pyoderma
7 registered clinical trials studyying Pyoderma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) NCT06563323 | Oregon Health and Science University | Phase 2 |
| Completed | Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG) NCT04901325 | Oregon Health and Science University | Phase 2 |
| Completed | Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma NCT05561816 | Valenta Pharm JSC | Phase 3 |
| Completed | Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma NCT04895566 | SWISS BIOPHARMA MED GmbH | EARLY_Phase 1 |
| Withdrawn | Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460) NCT00202891 | Merck Sharp & Dohme LLC | Phase 4 |
| Recruiting | A Real-World Registry of Chronic Wounds and Ulcers NCT02280733 | U.S. Wound Registry | — |
| Completed | Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territo NCT00884728 | Menzies School of Health Research | — |